Company · CIK 2096997

# Kailera Therapeutics, Inc.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

| CIK | [2096997](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002096997) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | KLRA (Nasdaq) |
| First annual or quarterly report | 2026-05-26 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-294690 | IPO Final prospectus | 2026-03-27 | 2026-04-17 | 4 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-04-17 | [424B4](https://www.sec.gov/Archives/edgar/data/2096997/000119312526161521/0001193125-26-161521-index.htm) Final prospectus | 333-294690 | 0001193125-26-161521 |
| 2026-04-16 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2096997/999999999526001217/9999999995-26-001217-index.htm) Declared effective | 333-294690 | 9999999995-26-001217 |
| 2026-04-13 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2096997/000119312526151904/0001193125-26-151904-index.htm) Amendment | 333-294690 | 0001193125-26-151904 |
| 2026-03-27 | [S-1](https://www.sec.gov/Archives/edgar/data/2096997/000119312526128952/0001193125-26-128952-index.htm) Registration filed | 333-294690 | 0001193125-26-128952 |
| 2025-12-19 | [DRS](https://www.sec.gov/Archives/edgar/data/2096997/000119312525326849/0001193125-25-326849-index.htm) Draft made public | 377-08841 | 0001193125-25-326849 |

[All filings of this company](https://equitycapital.markets/filings?cik=2096997) · [CSV](https://equitycapital.markets/filings.csv?cik=2096997)

---
Source page: https://equitycapital.markets/company/2096997 · Data: U.S. SEC EDGAR · CC BY 4.0